Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

Aug 25, 2004

29777_dirs_2004-08-25_186151c6-65e5-47ce-aed6-5014537a8cd3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-08-23

Reporting Person: LIEPMANN HOLGER A (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-08-23 Common shares without par value M 10284 $32.6111 Acquired 75196 Direct
2004-08-23 Common shares without par value F 8761 $41.01 Disposed 66435 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-08-23 Option (right to buy) $32.6111 M 10284 Disposed 2010-02-10 Common shares (10284) Direct
2004-08-23 Option (right to buy) $41.01 A 8761 Acquired 2010-02-10 Common shares (8761) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 12795 Indirect
Common shares without par value 295 Indirect
Common shares without par value 296 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 20, 2004.

F2: Reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.